Ποια είναι η τιμή για Yuhan Corporation (000100)

Η τιμή για Yuhan Corporation (000100) είναι $59.95

Ποια είναι η κεφαλαιοποίηση αγοράς για Yuhan Corporation (000100)

Η κεφαλαιοποίηση αγοράς για Yuhan Corporation (000100) είναι $4.41B

Yuhan Corporation (000100) Τιμή και Κεφαλαιοποίηση Αγοράς

Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.

Η τιμή για 000100	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$69,991.48 $4.41B	NVDA	$5.152T	+116,644.91%
$61,630.98 $4.41B	AAPL	$4.537T	+102,699.69%
$56,625.90 $4.41B	GOOG	$4.169T	+94,351.29%
$49,477.76 $4.41B	MSFT	$3.642T	+82,428.27%
$38,099.15 $4.41B	AMZN	$2.805T	+63,448.90%

Η τιμή για 000100

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$69,991.48 $4.41B